Produktinformation
Pptn trifluoroacetate is a drug candidate that is currently undergoing clinical trials as a potential treatment for Alzheimer's disease. It belongs to the group of pyridone derivatives, which are chemically related to butyrophenones. Pptn trifluoroacetate has been found to be effective in reducing the symptoms of Alzheimer's disease by inhibiting 5-HT1A receptor activation, which leads to increased brain levels of serotonin and dopamine. Pptn trifluoroacetate has also been found to have calcium binding properties that lead to increased release of acetylcholine from cells in the brain. This drug candidate has shown no significant side effects in animal studies and has been found to be safe for human use.
Chemische Eigenschaften
Technische Anfrage zu: 3D-KWB27130 Pptn trifluoroacetate
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.